Coronavirus COVID-19 Updates: uc.edu/publichealth
Search By:
By: University of Cincinnati Cancer Center
The University of Cincinnati Cancer Center Clinical Trials Office recently opened a trial to compare a lower-than-standard dosage of a widely used treatment in newly diagnosed acute myeloid leukemia (AML) patients. This clinical trial is designed to evaluate the efficacy this dosage and treatment schedule of Venetoclax plus Azacitidine may have for newly diagnosed AML patients.
By: Communications Staff
By: Karen Bankston, PhD, MSN
Black people have the highest death rate and shortest survival of any racial/ethnic group in the United States for most cancers. An underlying source of health disparities among people of color is structural racism, which is defined as discrimination perpetuated through interconnected institutions and reinforced through culture, history, ideology, and sanctioned practices.
231 Albert Sabin Way, Suite 2005Cincinnati, OH 45267Phone: 513-558-2177Fax: 513-558-2666